European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical OncologyHumansEsophageal NeoplasmsFemaleMaleSEER Program
Real-world survival benefit of adding immunotherapy to chemotherapy in esophageal cancer: A large SEER-based analysis.
Jing Chen, Hong-Jun Lin, Chang-Qing Liu
Published: 202510.1016/j.ejso.2025.110504
Abstract
BACKGROUND: The integration of immunotherapy with chemotherapy has shown promise in improving survival for advanced esophageal cancer. However, most supporting evidence comes from prospective trials with small cohorts, and large-scale real-world vali…
Preview only. Read the full abstract at the source